In humans, SDF-1a is constitutively released from the heart into the circulation at baseline, resulting in a positive gradient from the coronary artery to the coronary sinus (Table 1, Figure 2) and this release is suppressed after MI. Here, CXCL12 is linked to myocardial infarction.